The critical role of pulse oximetry screening for congenital heart disease and patent ductus arteriosus in newborns

HIGHLIGHTS

• What: The study focused on infants born with complex cardiovascular malformations admitted to the clinic over three years (January 2021 - December 2023). The aim of the comprehensive study was to showcase the remarkable impact of integrating POS, clinical assessment, and cardiac ultrasonographic examination in enhancing the early detection rates of CHD within the crucial 72-hour window following birth. This research has the potential to provide valuable insights for clinical guidelines and establish a uniform approach to healthcare across different institutions. This study evaluated neonatal screening for CHD in a NICU using pulse oximetry and clinical evaluation . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.